Status:
NOT_YET_RECRUITING
Intrathecal DEX With Bupivacaine Inpost-spinal Shivering After CS.
Lead Sponsor:
Al-Azhar University
Conditions:
Post Spinal Anesthesia Shivering
Eligibility:
FEMALE
20-40 years
Phase:
PHASE3
Brief Summary
This prospective, randomized, double-blind, placebo-controlled study to determine whether intrathecal dexmedetomidine, administered along with hyperbaric bupivacaine for covering Cesarean delivery dec...
Detailed Description
The study will be carried out at AL Azhar University Hospitals (Assiut) on 120 parturients belonging to ASA physical status I and II undergoing an elective cesarean delivery under spinal anesthesia pr...
Eligibility Criteria
Inclusion
- Full-term pregnant women undergoing elective cesarean section under spinal anesthesia.
- singleton pregnancy
- Age: 20 \~ 40 years;
- ASA physical status II \~ III;
Exclusion
- parturient less than 20 years and more than 40 years.
- History of uncontrolled comorbidities, cardiac (e.g., pre-eclampsia and hypertension), respiratory, renal or hepatic disease.
- parturients who had allergy to any medication in the study.
- parturients with contraindications to spinal anesthesia (coagulation disorder, infection at site of puncture, raised intracranial tension or any spine deformity)
- parturient who has history of alcohol intake.
- parturient received any medication likely to affect thermoregulation or Veno dilation.
- Refusing to sign informed consent.
Key Trial Info
Start Date :
May 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2025
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06942000
Start Date
May 1 2025
End Date
December 30 2025
Last Update
April 24 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Medicine, Al-Azhar University, Assiut, Egypt
Asyut, Egypt, 71523
2
Mohamed Ali Mahmoud
Asyut, Egypt, 71523